Rodriguez v. Secretary of Health and Human Services

United States Court of Federal Claims·Decided October 10, 2017·No. 13-253·Unpublished

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 13-253V Filed: September 15, 2017

* * * * * * * * * * * * * * * WILLIAM RODRIGUEZ and * UNPUBLISHED BRENDA RODRIGUEZ, as the * Parents and Natural Guardians of * C.R., a Minor, * * Petitioners, * v. * Decision on Interim Attorneys’ Fees and * Costs SECRETARY OF HEALTH * AND HUMAN SERVICES, * * Respondent. * * * * * * * * * * * * * * * *

Mark T. Sadaka, Esq., Mark T. Sadaka, LLC, Englewood, NJ, for petitioner. Linda S. Renzi, Esq., U.S. Department of Justice, Washington, DC, for respondent.

DECISION ON INTERIM ATTORNEYS’ FEES AND COSTS1

Roth, Special Master:

On April 9, 2013, William and Brenda Rodriguez (“Mr. Rodriguez” and “Mrs. Rodrigues” or “petitioners”) filed a petition on behalf of their minor child, C.R., pursuant to the National Vaccine Injury Compensation Program, 42 U.S.C. § 300aa-10 et seq.2 (“Vaccine Act” or “the Program”). Petitioners allege that the Diphtheria-Tetanus-acellular Pertussis (“DTaP”), Polio (“IPV”), Measles-Mumps-Rubella (“MMR”), and Varicella vaccinations that C.R. received on August 30, 2011, caused him to suffer from juvenile dermatomyositis. ECF No. 1.

1 Because this unpublished decision contains a reasoned explanation for the action in this case, I intend to post this decision on the United States Court of Federal Claims’ website, in accordance with the E-Government Act of 2002, Pub. L. No. 107-347, § 205, 116 Stat. 2899, 2913 (codified as amended at 44 U.S.C. § 3501 note (2012)). In accordance with Vaccine Rule 18(b), a party has 14 days to identify and move to delete medical or other information, that satisfies the criteria in 42 U.S.C. § 300aa-12(d)(4)(B). Further, consistent with the rule requirement, a motion for redaction must include a proposed redacted decision. If, upon review, I agree that the identified material fits within the requirements of that provision, I will delete such material from public access. 2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755 (1986). Hereinafter, for ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012). On August 7, 2017, petitioners’ counsel, Mr. Mark Sadaka, filed a Motion for Interim Fees. ECF No. 110. Mr. Sadaka requests $65,085.45 in interim attorneys’ fees and $18,999.14 in interim costs, for a total amount of $84,084.59. Id. at 17. For the reasons below, petitioners’ motion is granted.

I. Procedural History

Petitioners filed their petition on April 9, 2013, and filed medical records, and a statement of completion the following week. ECF Nos. 6-7. This case was originally assigned to Chief Special Master Dorsey.3 Respondent filed a Rule 4 Report on July 3, 2013, stating that, based “[on] the existing record, petitioners have failed to provide preponderant evidence in support of their claim,” and that respondent therefore “recommends that compensation be denied and the case be dismissed.” Resp. Rule 4 Report, ECF No. 10.

On February 20, 2014, petitioners filed an expert report from Dr. Eric. M. Gershwin. ECF No. 19. Respondent filed an expert report from Dr. Carlos D. Rose on June 3, 2014. ECF No. 23. Petitioners filed additional medical records, a statement of completion, and a supplemental report from Dr. Gershwin on October 17, 2014. ECF Nos. 38-40. Respondent filed a supplemental report from Dr. Rose on November 6, 2014. ECF No. 41.

On July 8, 2015, the parties filed a Stipulation for Interim Fees and Costs. ECF No. 55. On July 9, 2015, the Chief Special Master issued a decision awarding interim fees and costs in the amount of $50,560.50 based on the parties’ stipulation. Decision, ECF No. 56.

An entitlement hearing was held in May 2016. After the hearing the parties were encouraged to discuss settlement. A status conference was held on December 2, 2016, during which time the parties indicated that settlement of this matter did not appear feasible. The parties were then ordered to file post-hearing briefs. Order, issued Dec. 2, 2016, ECF No. 102.

Petitioners’ post-hearing brief was filed on March 10, 2017, and respondent’s post- hearing brief was filed the following month, on April 10, 2017. ECF Nos. 107-8.

On August 7, 2017, petitioners’ counsel filed his second Motion for Interim Attorneys’ Fees and Costs in which he stated that counsel has expended considerable fees and costs in this matter. ECF No. 110. On August 8, 2017, respondent filed a response to petitioner’s Motion for Interim Fees that contained no specific objection to the amount requested or hours worked, but instead “respectfully recommend[ed] that the Special Master exercise her discretion and determine a reasonable award for attorneys’ fees and costs.” ECF No. 111. Petitioner’s motion for interim fees and costs is now ripe for decision.

3 This case was reassigned to me on October 23, 2015. See Notice of Reassignment, ECF No. 63.

2 II. Legal Framework

The Vaccine Act permits an award of “reasonable attorneys’ fees” and “other costs.” § 15(e)(1). If a petitioner succeeds on the merits of his or her claim, the award of attorneys’ fees is automatic. Id.; see Sebelius v. Cloer, 133 S. Ct. 1886, 1891 (2013). However, a petitioner need not prevail on entitlement to receive a fee award as long as the petition was brought in “good faith” and there was a “reasonable basis” for the claim to proceed. § 15(e)(1). Moreover, special masters have discretion to award interim fees while the litigation is ongoing if “the cost of litigation has imposed an undue hardship” and there is “a good faith basis for the claim.” Shaw v. Sec’y of Health & Humans Servs., 609 F.3d 1372, 1375 (Fed. Cir. 2010); see Avera v. Sec’y of Health & Human Servs., 515 F.3d 1343, 1352 (Fed. Cir. 2008). One instance in which interim fees have been awarded is when “the cost of litigation has imposed an undue hardship.” Shaw v. Sec’y of Health & Human Servs., 609 F.3d 1372, 1375 (Fed. Cir. 2010); see Davis v. Sec’y of Health & Human Servs., No. 15-277V, 2016 WL 3999784, at *4 (Fed. Cl. Spec. Mstr. July 5, 2016). Because petitioners’ counsel has indicated that he has borne considerable fees and costs, see ECF No. 110 at 2, an award of interim fees and costs is appropriate in this case.

The Federal Circuit has endorsed the use of the lodestar approach to determine what constitutes “reasonable attorneys’ fees” and “other costs” under the Vaccine Act. Avera, 515 F.3d at 1349. Under this approach, “an initial estimate of a reasonable attorneys’ fees” is calculated by “multiplying the number of hours reasonably expended on the litigation times a reasonable hourly rate.” Id. at 1347-48 (quoting Blum v. Stenson, 465 U.S. 886, 888 (1984)). That product is then adjusted upward or downward based on other specific findings. Id.

A “reasonable hourly rate” is defined as the rate “prevailing in the community for similar services by lawyers of reasonably comparable skill, experience and reputation.” Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Rodriguez v. Secretary of Health and Human Services, (uscfc 2017).

Rodriguez v. Secretary of Health and Human Services (Rodriguez v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related